Table 3 The total noradrenaline dose administered at different time points and the total noradrenaline consumption in the 28 days in the three studied groups

Noradrenaline dose (mg)

T0

0.39 ± 0.12

0.42 ± 0.12

0.46 ± 0.11

0.076

T1

0.42 ± 0.13

0.41 ± 0.13

0.43 ± 0.12

0.713

T2

0.42 ± 0.13

0.40 ± 0.12

0.38 ± 0.12

0.533

T3

0.43 ± 0.13

0.37 ± 0.12

0.34 ± 0.12

0.022*

p1 = 0.167

p2 = 0.026*

p3 = 0.698

T4

0.39 ± 0.12

0.30 ± 0.13

0.26 ± 0.12

0.002*

p1 = 0.030*

p2 = 0.003*

p3 = 0.636

T5

0.31 ± 0.05

0.14 ± 0.06

0.06 ± 0.10

< 0.000*

p1 < 0.001*

p2 < 0.001*

p3 = 0.284

Total noradrenaline consumption at 28 days (mg)

133.8

(95.7-156.2)

92.9

(83.5–116.0)

82.9

(63.1–116.0)

< 0.001*

p1 = 0.002*

p2 < 0.001*

p3 = 0.751